Article | October 15, 2020

Paving The Way For Tomorrow's Medicines

Source: Nanoform
nanoform

Before new medicines can reach the patients who need them, there is a huge amount of R&D that takes place to ensure drug safety and efficacy. From preliminary drug discovery research to drug development and progression through clinical trials, before finally reaching the market, the release of a novel therapy is the culmination of often upwards of 10 years’ hard work.

In spite of the extraordinary efforts and the significant financial investment behind every drug candidate, only a small fraction will ever make it through clinical trials - less than 10%. A major reason for this is poor solubility and bioavailability of drug candidates. More than 40 percent of new chemical entities (NCEs) developed in the pharmaceutical industry exhibit poor aqueous solubility, and this issue is compounded by a trend towards more complex, hydrophobic molecules.

There is a great need for innovative technologies that can improve the success rate for new drug candidates and pave the way for novel therapies to reach the market. Recent advances in nanoparticle engineering technology promise to accomplish precisely this.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: